These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 28174259

  • 21. Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes.
    Okdahl T, Brock C, Fløyel T, Wegeberg AL, Jakobsen PE, Ejskjaer N, Pociot F, Brock B, Størling J.
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):419-428. PubMed ID: 32497255
    [Abstract] [Full Text] [Related]

  • 22. Proinflammatory cytokines predict the incidence of diabetic peripheral neuropathy over 5 years in Chinese type 2 diabetes patients: A prospective cohort study.
    Zheng H, Sun W, Zhang Q, Zhang Y, Ji L, Liu X, Zhu X, Ye H, Xiong Q, Li Y, Lu B, Zhang S.
    EClinicalMedicine; 2021 Jan; 31():100649. PubMed ID: 33385123
    [Abstract] [Full Text] [Related]

  • 23. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany).
    Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, Döring A, Thorand B, Holle R, Giani G, Martin S, Meisinger C.
    Diabetes Care; 2009 Apr; 32(4):680-2. PubMed ID: 19131463
    [Abstract] [Full Text] [Related]

  • 24. A clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies.
    Bongaerts BW, Ziegler D, Shaw JE, Heier M, Kowall B, Herder C, Roden M, Peters A, Meisinger C, Rathmann W.
    J Diabetes Complications; 2015 Apr; 29(1):44-9. PubMed ID: 25457462
    [Abstract] [Full Text] [Related]

  • 25. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF, Othman A, Hirshman SK, Bode H, Alecu I, Fähndrich E, Karges W, Weis J, Schulz JB, Hornemann T, Claeys KG.
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [Abstract] [Full Text] [Related]

  • 26. Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.
    Klüppelholz B, Thorand B, Koenig W, de Las Heras Gala T, Meisinger C, Huth C, Giani G, Franks PW, Roden M, Rathmann W, Peters A, Herder C.
    Diabetologia; 2015 Oct; 58(10):2269-77. PubMed ID: 26155746
    [Abstract] [Full Text] [Related]

  • 27. Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.
    Weng YC, Tsai SS, Lyu RK, Chu CC, Ro LS, Liao MF, Chang HS, Chen CM, Hwang JS, Kuo HC.
    J Diabetes Res; 2020 Oct; 2020():6356459. PubMed ID: 32695829
    [Abstract] [Full Text] [Related]

  • 28. Epidemiology of polyneuropathy in diabetes and prediabetes.
    Ziegler D, Papanas N, Vinik AI, Shaw JE.
    Handb Clin Neurol; 2014 Oct; 126():3-22. PubMed ID: 25410210
    [Abstract] [Full Text] [Related]

  • 29. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
    Seddon JM, George S, Rosner B, Rifai N.
    Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
    [Abstract] [Full Text] [Related]

  • 30. Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study.
    Hansen CS, Vistisen D, Jørgensen ME, Witte DR, Brunner EJ, Tabák AG, Kivimäki M, Roden M, Malik M, Herder C.
    Cardiovasc Diabetol; 2017 Dec 01; 16(1):153. PubMed ID: 29195493
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study.
    Lai YR, Chiu WC, Huang CC, Cheng BC, Yu IH, Kung CT, Lin TY, Chiang HC, Kuo CA, Lu CH.
    J Diabetes Investig; 2024 Mar 01; 15(3):326-335. PubMed ID: 38168098
    [Abstract] [Full Text] [Related]

  • 32. Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts.
    Herder C, de Las Heras Gala T, Carstensen-Kirberg M, Huth C, Zierer A, Wahl S, Sudduth-Klinger J, Kuulasmaa K, Peretz D, Ligthart S, Bongaerts BWC, Dehghan A, Ikram MA, Jula A, Kee F, Pietilä A, Saarela O, Zeller T, Blankenberg S, Meisinger C, Peters A, Roden M, Salomaa V, Koenig W, Thorand B.
    Arterioscler Thromb Vasc Biol; 2017 Jun 01; 37(6):1222-1227. PubMed ID: 28428221
    [Abstract] [Full Text] [Related]

  • 33. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E, Hu X, Michael N, Nyengaard JR, Truini A, Karlsson P.
    Acta Diabetol; 2022 Jan 01; 59(1):1-19. PubMed ID: 34213655
    [Abstract] [Full Text] [Related]

  • 34. Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary.
    Pető A, Tóth LI, Hernyák M, Lőrincz H, Molnár Á, Nagy AC, Lukács M, Kempler P, Paragh G, Harangi M, Ferenc S.
    PLoS One; 2024 Jan 01; 19(7):e0306482. PubMed ID: 38959204
    [Abstract] [Full Text] [Related]

  • 35. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study.
    Bongaerts BW, Rathmann W, Kowall B, Herder C, Stöckl D, Meisinger C, Ziegler D.
    Diabetes Care; 2012 Sep 01; 35(9):1891-3. PubMed ID: 22751964
    [Abstract] [Full Text] [Related]

  • 36. Neuropathic pain is not adequately treated in the older general population: Results from the KORA F4 survey.
    Meisinger C, Bongaerts BWC, Heier M, Amann U, Kowall B, Herder C, Rückert-Eheberg IM, Rathmann W, Ziegler D.
    Pharmacoepidemiol Drug Saf; 2018 Jul 01; 27(7):806-814. PubMed ID: 29797371
    [Abstract] [Full Text] [Related]

  • 37. Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes.
    Mizrak HI, Hansen TW, Rossing P, Curovic VR, Vistisen D, Amadid H, Hansen CS.
    Diabetes Care; 2023 Nov 01; 46(11):1997-2003. PubMed ID: 37647323
    [Abstract] [Full Text] [Related]

  • 38. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D, Landgraf R, Lobmann R, Reiners K, Rett K, Schnell O, Strom A.
    Diabetes Res Clin Pract; 2018 May 01; 139():147-154. PubMed ID: 29518491
    [Abstract] [Full Text] [Related]

  • 39. Association of persistent organic pollutants with sensorimotor neuropathy in participants with and without diabetes or prediabetes: Results from the population-based KORA FF4 study.
    Schwarz M, Wolf K, Schneider A, Schramm KW, Bongaerts B, Henkelmann B, Herder C, Roden M, Peters A, Ziegler D, Rathmann W.
    Int J Hyg Environ Health; 2021 Jun 01; 235():113752. PubMed ID: 34020228
    [Abstract] [Full Text] [Related]

  • 40. Diabetic neuropathies.
    Wein TH, Albers JW.
    Phys Med Rehabil Clin N Am; 2001 May 01; 12(2):307-20, ix. PubMed ID: 11345009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.